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INTRODUCTION 
Bone  tumours  are  relatively  uncommon.  The  precise  incidence  of 
specific  bone  tumours  is  not  known,  because  many  bone  lesions  are 
asymptomatic and are not biopsied.
In 1958,  Jaffe pointed out  the importance of  correlation between the 
surgeon, the radiologist and the pathologist in diagnosis of bone lesions 1.    
Tumours  of  the  skeletal  system  are  relatively  constant  in  their 
presentation. The five basic parameters of importance in this regard are the age 
of  the  patient,  bone  involved,  specific  area  with  in  the  bone  (epiphysis, 
metaphysis  (or)  diaphysis,  cortex,  medulla  or  periosteum),  radiographic 
appearance and microscopic appearance. The pathologist should be fully aware 
of the first four before trying to evaluate the fifth.
Symptoms are most often non specific in bone tumours. Most patients 
present  with  pain,  swelling  or  both.  Occasionally  the  patient  present  with 
pathological  fractures.  None  of  these  features  suggest  a  specific  diagnosis. 
However  there  are  some  lesions  of  bone  associated  with  specific 
symptomatology. A patient with an osteoid osteoma can presents with exquisite 
pain which is relieved with analgesic. A patient with Ewings sarcoma of bone 
may  present  with  fever  and  increased  ESR  suggesting  the  diagnosis  of 
osteomyelitis. This may lead to inappropriate therapy and delay in diagnosis. 
So symptoms are of limited value in arriving at a diagnosis.
The  age  of  the  patient  and  the  exact  location  of  the  tumours  are 
extremely important. Most of the highly malignant sarcomas such as Ewings 
sarcoma and osteosarcoma occur in children. Lower grade sarcomas such as 
chondrosarcoma occur in adults.
The location and extent of the lesion are of great importance. Giant cell 
tumour usually occur at the epiphyseal end of the bones.
A lesion containing a large number of giant cells occurring in a location 
such as metaphysis (or) diaphysis should suggest the possibility of some other 
process – such as hyperparathyroidism, osteosarcoma (or) Aneurysmal bony 
cyst. 
About half of the osteosarcoma arise around the knee either in the distal 
femoral (or) proximal tibial metaphysis.  A cartilaginous neoplasm involving 
the flat bone is a chondrosarcoma.
Roentgenographic  appearance  is  of  great  importance.  The 
roentgenogram  is  the  best  way  to  localize  the  lesion.  There  are  several 
radiological  features that  aid in diagnosing a benign from malignant  lesion. 
Benign tumours tends to be well circumscribed and may have a sclerotic rim. 
Malignant  tumours  tend  to  be  poorly  circumscribed.  Most  spindle  cell 
sarcomas tend to show geographic areas of destruction. Geographic destruction 
refers  to  a large hole  in  the  bone.  Small  cell  malignancies such as  Ewings 
sarcoma tends to show permeative destructive process, this refers to a moth 
eaten  appearance in  which  there  are  multiple  small  holes  in  the  bone  with 
intervening residual bone 1.
The  character  of  the  periosteal  reaction  is  important.  Benign  lesions 
such as Langerhan cell histiocytosis show thick, regular periosteal new bone 
formation. Malignant tumours such as Ewings sarcoma tends to form multiple 
layers of poorly organized new bone in the periosteum.
Existing  estimates  suggest  however,  that  benign  tumours  are  more 
frequent in males. Data concerning bone sarcoma are more comprehensive and 
reveal that males and females are affected at a ratio of 1 : 0.7.      
Although primary tumours develop in  all  parts  of  the skeleton,  most 
demonstrate a predilection for the long tubular bones. Benign tumours tend to 
arise in the appendicular skeleton, with approximately 45% developing in the 
femur and tibia, usually about the knee. In comparison to benign tumours, bone 
sarcomas  more  frequently  involve  the  pelvis  and  axial  skeleton  and  rarely 
affect the small bones of hands and feet.    
AIMS OF THE STUDY
1. To assess the diagnostic accuracy of fine needle aspirates of bone. The 
analysis compared the accuracy according to anatomical location, size 
type of lesion and histology.
2. To assess the diagnostic accuracy of core needle biopsy
3. To compare the diagnostic accuracy of Fine Needle aspiration and core 
needle biopsy
4. Comparative evaluation of other authors data with our study
REVIEW OF LITERATURE 
Neoplasms and tumour like conditions of bone are rare. Bone tumours 
tend to affect  young children and adolescents.  These factors  are a cause of 
concern  for  the  surgical  pathologist  dealing  with  a  bone  tumour  because  a 
diagnosis  of  sarcoma  will  result  in  extensive  surgery  and,  in  most  cases, 
chemotherapy with or  without  radiotherapy.  Historically,  the  diagnosis  of  a 
sarcoma often mandated amputation surgery and carried a poor prognosis.
The key to their accurate recognition is the utilization of an integrated 
approach that assesses and correlate the clinical, radiographic, morphologic and 
biologic behaviour of these lesions.
The first systematic classification of the tumours primary in bones was 
that  proposed by  the  registry  of  bone sarcoma of  the  American College of 
Surgeons – in  1920.  Ewing published an official  revision of  the  Registry’s 
classification. This revision has undergone further modifications by others, but 
still constitutes the care of the many of the later versions. 
Etiology :
Chromosomal mutations in mesenchymal stem cells are responsible for 
neoplastic transformation, proliferation and ultimately, bone tumour formation. 
Genetic  mutations  specific  to  particular  bone  tumour  type  are  infrequently 
identified. Benign and malignant bone tumours are, however, components of a 
variety  of  genetic  syndromes  including  olliers  disease,  Maffuci  syndrome, 
multiple hereditary osteochondromas, bilateral retinoblastoma, Li – Fraumeni 
syndrome,  Gardner  syndrome,  Mazabraud  syndrome,  McCune  –  Albright 
syndrome. Neurofibromatosis and diaphyseal medullary stenosis.
A variety  of  disease  create  conditions  within  bone  that  facilitate  the 
development of neoplasms, especially sarcomas. The most important of those 
are Paget’s disease, radiation injury, bone infarction and chronic osteomyelitis.
Pre  exisiting  bone  tumours  undergo  malignant  transformation 
infrequently  and  those  that  do  so  are  most  commonly  enchordroma  and 
osteochondroma; rarely does it occur with fibrous dysplasia or a simple bone 
cyst.
Recently,  reports  have  documented  the  development  of  sarcomas 
adjacent to orthopedic implants.  The incidence of this dreaded complication 
appears, however to be exceedingly small, and the carcinogenic properties of 
the chemical components of the implants in humans are thought to be minimal2. 
Classification of bone tumours :
     The classification that is used more or less universally is the one first 
proposed by Lichtenstein. Most bone tumours are classified according to the 
normal cell and tissue type they recapitulate.
The terminology and classification of bone tumours are recommended 
by the WHO international reference centre for the histological definition and 
the classification of bone tumours. In WHO classification, most neoplasm are 
classified as either benign (or) malignant. Some neoplasms exhibit borderline 
(or)  intermediate  characteristics,  such  as  GCT  and  well  differentiated 
cartilaginous tumours. Most malignant bone tumours arise de novo, but there is 
a  small  number  of  benign  bone  lesions  that  predispose  the  patient  to  the 
development  of  skeletal  malignancies.  These  include  pagets  disease, 
chondromatosis,  osteochondromatosis,  fibrous  displasia  and  osteofibrous 
dysplasia3.
Classification of primary tumours of the bone.
Histological type Benign Malignant
Hematopoietic (40%) Myeloma
Malignant lymphoma
Chondrogenic (22%) Osteochondroma
Chondroma
Chondroblastoma
Chondromyxoid fibroma
Chondro sarcoma
Clear cell chondro sarcoma
Myxoid chondro sarcoma
Dedifferentiated 
Chondro sarcoma
Mesenchymal chondro 
sarcoma
Osteogenic (19%) Osteoid osteoma 
Osteoblastoma
Osteosarcoma
Unknown  origin Giant cell tumour Ewings tumour
(10%) Giant cell tumour
Adamantinoma
Histiocytic origin Fibrous histiocytoma Malignant  fibrous 
histiocytoma
Fibrogenic Metaphyseal  fibrous 
defect (fibroma)
Desmoplastic  fibroma 
Fibro sarcoma 
Notochordal Chordoma
Vascular Heamangioma Hemngio Endothelioma
Hemangio pericytoma
Neurogenic Neurilemmoma
Sub classification of osteosarcoma :-
Osteosarcoma within bone :-
Conventional Osteosarcoma Surface osteosarcoma
- Osteoblastic Parosteal osteosarcoma
- Chondroblastic Periosteal osteosarcoma
- Fibroblastic High grade osteosarcoma
• Small cell
• Telengiectactic
• Low grade central
• Osteosarcoma in pagets disease 
• Post irradiation osteosarcoma
• Osteosarcoma in other benign precursors
Among the bone tumours, osteosarcoma and the fibrous cortical defect 
are the most frequent.  Excluding malignant neoplasm of the marrow origin, 
(myeloma,  lymphoma  and  leukemia)  osteosarcoma  is  the  most  common 
primary cancer of bone followed by chondrosarcoma and Ewings sarcoma4.
Metastatic tumours of the bone 4
Are the  most  common form of  skeletal  malignancy.  Any cancer  can 
spread to bone.
The pathways of spread include 
1. Direct extension
2. Lymphatic (or) vascular dissemination and
3. Intraspinal seeding (Batson plexus of veins)
In adults, more than 75% of skeletal metastasis originate from cancer of 
the prostate, breast, kidney and lung.
Soft  tissue  sarcomas  rarely  metastasize  to  the  skeletal  system,  the 
outstanding exception being Embryonal Rhabdo Myo Sarcoma (RMS) of the 
soft  tissue  in  children.  In  children  metastases  to  bone  originate  from 
neuroblastoma. Wilms tumour, osteosarcoma, Ewings sarcoma and RMS. In all 
bones, metastases are preferentially situated in red bone marrow. 
Skeletal  metastases  are  typically  multifocal;  however,  carcinoma  of 
kidney and thyroid are notorious for producing solitary lesions.
The  metastases  may  occur  in  any  bone,  but  most  involve  the  axial 
skeleton  (vertebral,  pelvis,  ribs,  skull,  sternum and  humerus  in  descending 
order  of frequency.  Metastases to the small  bone of the hands and feet  are 
uncommon and usually originate in cancers of lung, kidney (or) colon.
The radiological manifestation of metastases may be purely lytic, purely 
blastic (or) mixed lytic and blastic. In lytic lesions, the metastatic cells secrete 
substances  such  as  prostoglandins,  ILs  and parathyroid  hormones  –  related 
protein  that  stimulate  the  osteoclastic  bone  resorption,  the  tumour  cells 
themselves do not directly resorb bone. Carcinoma of lung, kidney, GIT and 
melanoma produce this type of bone destruction.
Metastases  that  elicit  a  sclerotic  response  particularly  prostatic 
adenocarcinoma  do  so  by  stimulating  osteoblastic  bone  formation.  Most 
metastases induce a mixed lytic and blastic reaction.
The  bones  involved  and  the  character  of  the  changes  seen 
radiographically are helpful in predicting the site of the primary neoplasm.
Thyroid carcinoma usually  metastasizes  to  the  bones  of  the  shoulder 
girdle, skull, ribs, sternum, flat bone of pelvis, femur and scapula. Exuberant 
new  bone  formation  can  also  occur,  because  of  the  pathological  fracture 
associated with metastatic carcinoma. Any tumor metastatic to bone may lead 
to hypercalcemia and elevation of serum acid phosphatase4.
PRINCIPLES OF BONE TUMOUR DIAGNOSIS
The diagnosis of bone tumours has always been difficult in part because 
of their absolute rarity (< 1% of all malignant neoplasms).
Proper and accurate diagnosis of bone tumours require multidisciplinary 
involvement.
Diagnosis of bone lesion should be approached from a dynamic stand 
point with the pathologist working in close colobration with the radiologist and 
orthopedic surgeon.
Radiological diagnosis :    
 Radiology  is  of  great  importance  in  the  diagnosis  of  bone  tumors. 
Radiograph should always be available to the pathologist,  who should never 
make a definite diagnosis without knowing the radiological features.
The  following  points  should  be  ascertained  from  a  radiographic 
examination of a bone lesion5.
1. Type of bone affected (Tubular (or) flat)
2. Sit of lesion – Epiphysis, metaphysis, diaphysis, growth plate
- medullary, cortical (or)
Juxta Cortical location 
3. Total length and circumference of the bone affected
4. Nature of any bone changes present – destructive, proliferative, moth 
eaten, permeative (or) geographic
5. Character of the margin of the lesion (sharp, ill defined)
6. Character of the periosteal reaction (laminated, onion peal, sun burst 
solid, codmans triangle)
Combining clinical and radiographic information helps the pathologist 
provide a more accurate and definite diagnosis5. 
Radiological features favouring benign versus malignant lesions
S.No. Benign Malignant 
1. Geographic destruction Moth eaten and permeative 
destruction 
2. Occasionally moth eaten Rarely Geographic
3. Non  aggressive  rim  of  bone 
sclerosis
Absence  of  non  aggressive  bone 
sclerosis
4. Periosteal  reaction uncommon 
if  present  –  usually  smooth, 
solid uninterrupted 
Periosteal reaction common and often 
interrupted spiculatd and lamellated
5. Absence  of  soft  tissue 
extension 
Soft tissue extension common 
Fine Needle Aspiration of bone tumours :
Aspiration cytology of bone tumours was introduced in 1930s. Needle 
biopsy is a rapid effective and safe method of evaluating unsuspected lesion of 
bone6.
The use of needle aspiration biopsy in the diagnosis of skeletal lesions 
was first introduced by Coplay et al in 1931 and later by Martin and Ellis in 
19347.
Synder and Coley reported in 1945 their experience with needle biopsy 
in bone tumor with an accuracy of 72% in primary lesion. Vertebral biopsies 
were first reported by Robertson and ball in 19327. 
Encouraging  results  obtained  by  Bhatia  and  Sharma  (1984)  have 
prompted the adoption of the procedure as major pre operative diagnostic tool.
FNAC  of  bone  performed  at  the  university  of  Texas  MD Anderson 
hospital during the period January 1978 to December 1986 were reviewed6. 
FNA is a powerful tool in the multi disciplinary approach to the diagnosis and 
management of osteosarcoma. The two important limitation of technique are 
that  densely  osteoblastic  tumours  often  yield  poorly  cellular  aspirate  and 
osteiod cannot be identified confidently on cytological smear. Inspite of these 
limitations, FNA is an extremely useful procedure in the current diagnosis and 
management of bone tumours. The most significant limitation of FNA is the 
inability to detect osteoid6.
FNA  is  an  excellent  for  confirming  the  diagnosis  of  metastatic 
malignancy. It is not good for diagnosing primary tumours. It  is possible to 
diagnose  a  malignancy  in  cases  of  osteosarcoma.  But  it  is  not  possible  to 
subclassify the type of osteosarcoma on the basis of material obtained in FNA1. 
FNA are inappropriate for the diagnosis of cartilaginous tumours. FNA are less 
useful to diagnose benign neoplasm. However cytological material should be 
interpreted with the full knowledge of the clinical and radiologic features of the 
lesions1.
Most cytopathologist define FNAC as the use of 22 guage needle, the 
risk of  needle tract  seedling is  exceedingly  low and appears to be  between 
0.003% and 0.009%. among bone tumours, false +ve rate range from < 1% - 
5% and false negative rates ranges from approximately 2% - 15%5.
Although  the  value  of  FNAC  in  distinguishing  malignancy  from 
benignancy  approaches  and  exceeds  90%,  its  accuracy  for  establishing  a 
specific histologic subtype has been for less tested5.
ANDRIS  KREILBERGS  and  Colleagues  evaluate  the  diagnostic 
accuracy  of  FNAC  in  a  prospective  study  of  300  patients  with  previously 
undiagnosed bone lesions. FNAC was performed under radiological control as 
an OP procedure.  The diagnosis  was  correct  in  239 (95%) cases  providing 
adequate  cytological  material.  There  were  8  (3%)  falsely  malignant. 
Chondrosarcoma gave the greatest diagnostic difficulty and Ewings sarcoma 
the least. This study suggest that FNAC is a valid option for the diagnosis of 
bone  tumours.  It  is  a  simple  out  patient  procedure  which  gives  sufficient 
cytological material for the correct diagnosis in 80% of cases. The cytological 
assessment must agree with the clinical and radiological findings8.
Elkhoury et al (1983) noted that the predictive value of a positive results 
is 100% and therefore a positive diagnosis can be considered definitive. Further 
biopsy  then  is  unnecessary.  After  a  negative  result  one  may  repeat  the 
aspiration (or) proceed with an open biopsy9.
Hajdu and Melamed (1984) have emphasized the basic limitation of the 
technique.  The  histological  architecture  is  lost  in  aspiration  samples.  The 
drawback was  overcome by  processing  the  blood clot  separately.  This  was 
studied  by  Hewes,  Vigorita  and  Freiberger  (1983).  The  osseous  blood  was 
considered better diagnostic material even, when compared to bone core. These 
authours stress that the osseous blood should be treated as a tissue specimen 
and not discarded9.
Tumours  that  are  predominantly  sclerotic  may  not  be  adequately 
sampled especially with FNAC. Bone tumours usually not amenable to needle 
biopsy include the following 
Osteoma
Osteoid osteoma
Osteoblastoma
Enchondroma
Low grade chondro sarcoma
Metaphyseal fibrous defect
Low grade osteosarcoma Fibrous dysplasia
Osteofibrous dysplasia
Hemangioma 
Core needle biopsy : CNB
Is a rapid, effective and safe method of evaluating unsuspected primary 
lesion of bone. The accuracy rate of procedure was 93%5.
It generally involves obtaining cores of tissue using a 14 guage (or) 18 
guage needle. Vertebral biopsies were first reported by Robertson and Ball in 
193210. 
Indications for CNB:
1. Patients with a known primary tumour who have a solitary bone lesion 
detected by conventional radiography, CT and MRI
2. Differentiating  primary  from  metastatic  bone  lesion,  when  the  H/o 
primary lesion is not known
3. For  evaluation  of  debilitated  patients  with  bone  lesion  that  are  not 
readily accessible to open biopsy
4. In whom a long surgical procedure would not be tolerated
5. Evaluation of small round cell tumour with first approach to diagnosis
6. Radiographically  typical lesion in an unusual age presentation
7. Suspected infection with radiographic features suggesting malignancy
A variety of needle are available for both trephine and aspiration biopsy 
1. Vim Silverman
2. Westernan – Jensen Needle 
3.Kormed needle
4. Craig needle
5. Meunier needle
6. Akerman needle
7. Jamsidhi needle
8. Vim tru cut needle
9. Thin walled needle
Contra indication of CNB :
Low platelet count < 50,000 (or) the presence of bleeding diatheses
Although CNB is less likely to result in complication its accuracy is far 
less than that possible with open biopsy.
Advantages of CNB over FNAC
Provides  a  chunk  of  tissue  that  allows  to  examine  the  tumour 
architecture. This is not possible with FNAC.
Disadvantages of CNB :
The biopsy procedure is relatively blind, so the ideal areas of the lesion 
may not be sampled. 
OPEN BIOPSY
Open  biopsy  has  been  the  most  common  and  conventional  method 
closed biopsy is gaining increasing popularity.
Open biopsy Closed biopsy
1
.
Requires  an  incision  under  operating 
room condition
No incision is required. Tissue 
specimen  is  obtained 
following  skin  puncture  by 
needle (or) trephine
2
.
Decrease  the  likelihood  of  sampling 
error
3
.
Enable  to  obtain  a  relatively  large 
amount of tissue for a diagnosis 
4
.
Complications are more No complications 
Accuracy  of  closed  biopsy  is 
80% 
PATIENT IN CLINIC
Palpable Mass Non Palpable Mass
CNB in Clinic CNB in Radiology 
Adequate Tissue Adequate Tissue 
Inadequate Tissue 
Open Biopsy
Final resection
Histological  features  favouring  Benign  and  malignant  lesions  in  bone 
tumors 5
Benign Malignant
1. Well circumscribed , non invasive Permeation and invasive
2. Absence of lamellar bone trapping Presence  of  lamellar  bone 
trapping
3. If  bone  production,  bone  rimmed 
by  at  least  a  single  row  of 
osteoblasts
Absence of osteoblast 
rimming
4. Soft tissue extension rare Common
5. Anaplasia lacking Common
6. Mitosis  less  commonly  numerous 
and virtually never atypical
Mitosis  numerous  and  often 
atypical
The biopsy should be regarded as a final diagnostic procedure. In any 
event  it  should  be  preceded by  a  careful  evaluation  of  the  clinical  history, 
physical examination, analytical study of the pertinent X – ray picture and the 
consideration of any relevant hematologic and chemical laboratory data.
The surgeon, the radiologist and the pathologist, individually is able to 
view the diagnostic problem not only from his angle, but from that of the other 
two11.  
  
COMPARISON OF FINE NEEDLE ASPIRATION BIOPSY, CORE NEEDLE BIOPSY AND OPEN BIOPSY5
Characteristics FNAC CNB Open Biopsy
Technical ease of procedure Easily learned and applied Easily learned and applied Difficult, requires special 
training 
Histological tissue Usually most helpful for 
ancillary studies, not 
morphology
Helpful for morphology and 
ancillary studies
Helpful for morphology and 
ancillary studies
Speed of interpretation Fast, often within minutes to 
hours
Tissue requires fixation and 
processing (1-2 days)
Tissue requires fixation and 
processing (1-2 days)
Risk of complications Exceedingly low Low, but higher than FNAC Low, but significantly higher 
than either FNAC (or) CNB
Risk of tumour contamination 
of biopsy site
Exceedingly low Low, but higher than FNAC Low, but significantly higher 
than either FNAC (or) CNB 
Accuracy rate for histological 
subtyping
Low 75 – 90%, more accurate for 
sub typing than FNAC
> 95%
Grading and staging of bone tumours 
Largely through the efforts of Enneking and Colleagues, the orthopedic 
oncologists from Florida, a staging system has become universally accepted 
that is based on two criteria : histologic grade and the anatomic location of the 
tumour.
The first criterion for the staging system is the grade of the neoplasm. In 
one  system,  proposed  by  the  National  cancer  institute,  necrosis  is  very 
important  factor in grading neoplasms.  The authors believed that the more 
necrotic tumour, the worse the prognosis. The high grade tumours tend to be 
more necrotic13.
The  grading  system  is  based  predominantly  on  the  cytologic 
characteristic  of  the  tumour  cells.  If  the  tumour  cells  closely  resemble  the 
tumour  cells  from  which  they  are  supposed  to  arise,  the  tumour  is  well 
differentiated, if a tumour is so undifferentiated that one can hardly recognize 
the normal counterpart, the tumour is poorly differentiated. The authors grade 
most bone tumours from 1 to 4, depending on the nuclear changes and to a 
lesser extent, the cellularity of the lesion.
In the staging system of Enneking and colleagues, tumours are classified 
as low grade (or) high grade. The low grade tumours in Enneking system are 
grade  1  and  2  in  the  broders  system  and  the  high  grade  tumours  in  the 
Enneking system are grades 3 and 4 in the Broders system.
Enneking and Colleagues Broders
Low grade Grade 1
Grade 2
High grade Grade 3
Grade 4
  
The anatomic location of the tumour depends on whether the lesions is 
confined to one compartment (or)  involves more than one compartment for 
bone tumours, lesions confined within the bone are considered to be in one 
compartment, and lesions that have broken through the bone into soft tissues 
are considered to involve two compartments.
Low grade tumours are considered stage I, high grade tumours are stage 
II. A neoplasm of any grade that has metastasized is considered stage III. Each 
stage  comprises  subdivisions  A  and  B,  depending  on  whether  the  tumour 
involves one compartment or more than one compartment.
STAGING OF BONE NEOPLASMS
Stage Grade Site Metastasis
IA 1 T1 M0
IB 1 T2 M0
IIA 2 T1 M0
IIB 2 T2 M0
IIIA 1,2 T1 M1
IIIB 1,2 T2 M1
 T1 : involves one compartment
T2 : involves more than one compartment
(lesions that have broken through the bone into soft tissues)
M0 : No metastatic tumours ;
M1 : Metastatic lesions present
The two, three (or) four tiered grading systems currently used are based 
on the assessment of standard, morphologic criteria,  including the degree of 
differentiation,  cytologic  atypia,  mitotic  activity  and  necrosis.  The  goal  of 
different  tiered  system  is  to  distinguish  sarcomas  associated  with  a  low 
probability  of  dissemination (low grade; < 25% chance of  metastasis)  from 
those that are aggressive and have a high risk of system spread (high grade > 
25% chance of metastasis) 2. 
Histopathologic grading 2
TNM two grade system Three grade system Four grade system
Low grade Grade 1 Grades 1 or 2
High grade Grade 2  (or) 3 Grades 3 or 4
Grade 1 Grade 2 and 3
Low grade High grade
Hypocellular to moderately cellular Moderately to densely cellular
Mild cytologic atypia Moderate to severe cytoloic atypia
Few mitosis Atypical mitosis
Minimal necrosis More area of necorsis
American Joint Committee on cancer staging system of bone sarcomas  2 . 
Primary tumour 
Tx : Primary tumour cannot be assessed
T0 : No evidence of primary tumour
T1 : Tumour ≤ 8cm in greatest dimension
T2 : Tumour > 8cm in greatest dimension
T3 : Discontinuous tumours in primary bone site
Regional lymph nodes (N)
Nx : Regional lymphnodes cannot be assessed
N0 : No regional lymph node metastases
N1 : Regional lymphnode metastasis
Distant metastasis (M)
Mx : Distant metastasis cannot be assessed
M0 : No distant metastasis 
M1 : Distant metastasis
M1a : Lung
M1b : Other distant sites.
Prognostic significance of alkaline phosphatase measurements in patients 
with osteogenic sarcoma.
Alkaline phosphatase (AP) is an enzyme whose function is to catalyze 
the hydrolysis of monophosphoric esters in an alkaline medium. In bone, this 
enzyme is thought to be involved either in the calcification of bone matrix or in 
the protein synthetic activity associated with bone matrix production. Different 
isoenzymes of AP are produced by different organs and this has been used to 
localize the source of circulating serum AP14.
Elevated levels of serum AP in the preoperative tumour bearing patient 
appear to be correlated with a poor prognosis. Serum AP levels almost always 
return to normal in the weeks following amputation.
Bone conditions other than osteosarcoma which results in elevated AP 
levels include
1. Fibrous dysplasia
2. Bone fractures
3. Osteomyelitis  
Ancillary techniques in diagnosis of bone tumours
1. Histochemistry :
a. Periodic acid Schiff
The positive PAS reaction demonstrates  mucopolysaccharides in new 
bone, calcifying cartilage. PAS assists in diagnosis of some mucinocus metastic 
tumours and primary tumours with glycogen Ex : Ewings sarcoma, PAS is very 
much  helpful  in  differentiating  Ewings  sarcoma  from  small  cell  variant  of 
osteosarcoma. The presence of PAS positive glycogen within the cytoplasm of 
tumour cells (as demonstrated by PAS stain) is diagnostic of Ewings tumour33.
b. Techniques for the demonstration of acid phosphatases
Gomari  (1941)  Alkaline  phosphatase  technique  –  Tumour  cells  are 
intensely  positive  for  alkaline  phosphatase  in  osteosarcoma,  a  feature  of 
diagnostic value.
c. Reticulin stains is useful in the differential diagnosis of Ewings sarcoma and 
malignant lymphoma
This histochemical characteristics helps to distinguish a primary bone 
lesion from metastatic pleomorphic malignancies such as spindle or anaplastic 
sarcoma like carcinoma, melanoma and primary spindle cell sarcoma of bone.
2. Electron microscopy (EM) :
EM examination of aspirated material may help to confirm the presence 
of osteoid.
Ultra  structurally,  the  better  differentiated  osteosarcoma tumour  cells 
resemble normal osteoblasts in their abundance of dilated cisternae of granular 
endoplasmic reticulum and sparse mitochondria. The matrix is formed of non 
periodic  fibrils,  scattered  collagen  fibers,  and  focal  calcium  deposits  of 
hydroxyapatite crystals3.
The  cells  of  well  differentiated  tumours  show  cytoloplasmic 
accumulation  of  glycogen,  lipid  droplets  and  dilated  cisternae  of  granular 
endoplasmic reticulum.
The  cells  of  Ewings  sarcoma  show  a  rather  primitive  appearance. 
Occasionally, a few dense core granules will be found, either in the cytoplasm 
or in the cell prolongations.
3. Immunohistochemistry
Cells  of  osteosarcoma  consistently  express  vimentin.  In  some  cases, 
smooth muscle actin and desmin are positive. S – 100 protein is always present 
in  foci  of  chondroid  differentiation,  proteins  –  osteonectin,  osteocalcin, 
osteopontin,  bone  morphogenetic  protein  have  been  identified  in  cells  of 
osteosarcoma and may be of utility in differential diagnosis of osteosarcoma.
Cells  of  chondrosarcoma are  positive for  S100 protein and collagens 
type II and V
Cells of Ewings sarcoma are consistently positive for vimentin. Postivity 
has been described for neuron specific enolase, protein gene product 9.51 Leu 7 
and neunofilament. CD99 is a cell membrane protein coded by a gene located 
on the short arms of the X and Y chromosomes that is consistently expressed 
by the cells of Ewings sarcoma.
Cells of chordoma shows reactivity for S100 protein, keratin, epithelial 
membrane antigen, HBME – 1, cathepsin, but only rarely for CEA. Strong 5 – 
nucleotidase  positivity  has  been found in  the  cell  membrane of  the  tumour 
cells, another features of diagnostic utility3.
4. Molecular genetic studies : 
  The most common cytogenetic abnormalities detected in osteosarcoma 
involve chromosomes 1,2,6,12.
Over  95%  of  the  cases  of  Ewings  sarcoma  show  on  cytogenetic 
examination the reciprocal translocation 11 : 22 (q24 : q12) which result in 
fusion of  the  EWS gene with  the  FL1 genes.  These  translocation has  been 
detected by RT – PCR, FISH technique in fresh frozen sections and paraffin 
sections3. 
MATERIALS AND METHODS 
The present study analyses the role of FNAC in the diagnosis of bone 
lesions in comparison with other techniques.
110 patients with bone tumours were referred to Pathology Department 
for diagnosis during the period from 2004 to 2006. All had been examined by 
plain radiography, CT and (or) MRI patients with suspected local recurrence of 
a  primary  malignant  bone  tumour  (or)  a  metastatic  lesion  of  a  previously 
diagnosed malignancy were also included in our study.
Methods
Procedure of FNAC:
We  performed  fine  needle  aspiration  cytology  as  an  outpatient 
procedure after studying the x – ray of the patient.
Requirements 
1. Syringe 5-10 ml disposable
2. Needle 23-18 guage with 2.54 to 3.8cm length
3. Glass slides : clean, dry, free of grease and dirt
4. Isopropyl alcohol fixation
5. Gloves
6. Skin disinfectants, cotton swabs, sterile dressing
7. Culture bottle – if required  
Aspiration technique :
After  preparation of  the  patient  and  careful  scrutiny  of  X –  ray,  the 
biopsy needle is  introduced along the long axis  of  the lesion into the extra 
osseous compartment. A vaccum is created by pulling back the plunger of the 
syringe and the aspirate is obtained by moving the needle in a gentle back and 
forth motion while continuing to apply suction, there by drawing tissue into the 
needle.  After  several  seconds,  the  suction  is  released  and  the  needle  is 
withdrawn from the lesion.
Each aspirate was placed on to a several slides, smears prepared, and 
fixed in isopropyl alcohol. They were routinely stained with hematoxylin and 
eosin. The various cytomorphological features of bone lesions were studied, 
analysed and placed in appropriate category.
CYTOLOGICAL FINDINGS IN BONE TUMOURS
 Normal structure : seen in FNA of bone lesions
1. Haematopoietic tissue
2. Osteoblasts – are commonly seen in aspirates from all  kinds of bone 
lesions
3. Osteoclasts
4. Chondrocytes
5. Cartilage
6. Mesothelial cells – seen in smears from spinal aspiration 
Neoplasms :-
Benign tumours of bone
1. Giant cell tumours (GCT) : 
Shows  cellular  smear  with  giant  cells  of  osteoclastic  type  and 
mononuclear spindle cells in the stroma. The gaint cells are typically attached 
to the periphery of clusters of spindle cells5.
2. Chondroma :
Shows predominatly cartilaginous tissue fragments and cells in lacunar 
spaces  within  fragments.  The  chordromyxloid  ground  substances  is  usually 
abundant.  The  tumour  cells  are  uniform  and  rounded  with  a  well  defined 
cytoplasm, rounded nuclei and one (or) two nucleoli
3. Chondroblastoma 
 Fragments of chondroid matrix and double cell population are the clues 
to  the  diagnosis.  They are  mononuclear  and  rounded with  well  demarcated 
cytoplasm  and  rounded,  lobulated  (or)  renifrom  nuclei.  Another  cells  are 
multinucleated osteoclastic type of giant cells. 
4. Chondromyxloid Fibroma
Smears show a mixture of chondroid fragments, fibroblast like spindle 
cells and osteoclast like giant cells embedded in myxoid material.
Primary malignant tumours of bone :
1. Osteosarcoma
Smears  contain  both  dissociated  neoplastic  cells  and  cell  clusters. 
Osteoid is seen as clumps of amorphous, faintly eosinophillic material in the 
background (or) between cells in clusters. Both benign osteoclastic giant cells 
and  malignant  giant  cells  with  pleomorphic  nuclei  are  commonly  seen. 
Pleomorphic spindle and rounded cells and tumour cells resembling osteoblasts 
are seen.
 The  hallmark  of  chondroblastic  osteosarcoma  on  FNA  is  the 
characteristic gelatinous chondroid matrix.
2. Chondro Sarcoma.:
Criteria for diagnosis 
1. Predominantly tissue fragments in lowgrade tumours, single cells may 
predominate in high grade sarcoma
2. Abundant eonsinphillic, vacuolated cytoplasm
3. Chondromyxoid material.
The tumor cells have a well defined cytoplasm and rounded nuclei with 
one (or) two nucleoli, binucleate cells are presnet and nuclear pleomorphism is 
of moderate degree.
3. Chordoma 
The  characteristic  findings  are  the  abundant  background  of  myxoid 
ground  substance  and  the  large,  physaliphorous  cells  with  abundant  pale, 
vacuolated,  buddly  cytoplasm  and  well  defined  cell  borders.  Clusters  of 
markedly pleomorphic cells with rounded nuclei are seen.
4. Ewing’s sarcoma 
Smears are highly cellular and are composed of both single cells and 
groups of loosely cohesive cells. There is a characteristic mixture of two types 
of cells. One has abundant pale cytoplasm with vacuoles (or) large clear spaces, 
rounded or ovoid nuclei with a dense chromatin. The cytoplasmic vacuoles (or) 
clear spaces correspond to large deposits of glycogen.
5. Malignant lymphoma
Cytologic criteria for diagnosis are 
i. A monotonous population of small lymphoid cells
ii. Mainly  round  nuclei  slightly  larger  than  those  of  normal  small 
lymphocytes 
iii. Charactertically coarse granular nuclear chromatin
6. Langerhans cells histiocytosis : (Eosinophillic granuloma)
The characteristic  histiocytes have moderately larger and paler nuclei 
with irregular and folded outline. The chromatin is entirely bland and nucleoli 
are  small.  The cytoplasm is  abundant  and pale  and has  fairly  well  defined 
borders and is often vacuolated.
Variable numbers of eosinophils and giant cells of histiocyte type are 
seen.
Vascular lesions :
Hemangioma :
Only blood is aspirated A few cells may be present among the blood, 
such  as  strands  of  endothelial  cells,  hemosiderin  containing  macrophasges 
osteoblasts and fibroblasts.
Solitary plasmacytoma5
Smear shows uniform dispersed population of  plasma cells  including 
multinucleate and pleomorphic forms. The eccentric nucleus with speckled (or) 
clock  face  chromatin  and the  abundant  amphophilic  cytoplasm and  a  clear 
cytoplasmic zone near the nucleus is another distinctive cytologic feature.
Core Needle Biopsy :
Core needle biopsy is another method of diagnosing bone tumours. The 
amount of diagnostic material varies depending on the size of the needle used 
for the procedure which can range from 18-11 (or) 12 guage. A needle biopsy 
is performed by a radiologist / orthopaedicians under CT (or) ultra sonographic 
guidance. The specimen typically consists of smear and biopsy tissue. Core 
needle  biopsies  were  placed  in  10% formalin,  processed  and  embedded  in 
paraffin wax, sectioned and stained for routine histopathological examination.
Handling of Specimens :
Most  bone  neoplasm  with  soft  tissue  were  processed  without 
decalcification.
Rare  tumours  ex:  osteoid  osteoma,  parasteal  osteosarcoma  were 
mineralized and needed decalcification.
If  the  resected  specimens  received  contains  both  soft  and  hard 
fragments, the hard materials were separated from the soft tissue, especially in 
the case of small cell neoplasm,
For decalcification, we used 5% nitric acid in 10% formalin.
For resected specimens of bone tumors we usually dissect away all the 
soft material, leaving only the involved bone and soft tissue extension by the 
neoplasm.
Using a bone saw, we bivalve the bone with the tumours.  Even thin 
slices of bone can be prepared for decalcification with the bone saw.
Amputation  specimens  were  handled  in  the  same  way  as  resection 
specimens.
Procedure of hematoxylin and eosin stain :  
• Dewax the section, dehydrate through graded alcohol to water
• Remove fixation pigments if necessary 
• stain in hematoxylin for 5 minutes
• Wash well in running tap water
• Differentiate in 1 percent acid alcohol for 2-4 seconds
• Wash well in running tap water until sections are again blue for 15 to 20 
minutes
• Stain in eosin for one minute
• Wash in water for 5 minutes
• Dry and mount the slide.
RESULTS 
Out of 110 patients with bone tumours, FNAC was done for 67 patients. 
The  cytological  diagnosis  was  compared  with  histological  diagnosis  after 
needle  biopsy  and  open  biopsy  in  47  cases.  In  20  cases,  there  was  no 
histological confirmation and the diagnosis was based on cytological analysis 
in combination with radiological and clinical features.
AGE  AND  SEX  DISTRIBUTION  OF  PATIENT  AT  INITIAL 
DIAGNOSIS  
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A  slight  male  predominance  was  noted  (1.3.1)  Ages  at  initial 
presentation ranged from 2 to 70 yrs (median age 16 years). The majority of the 
patients  (36.4%)  were  with  in  the  2nd decade  of  life  at  the  time  of  initial 
diagnosis.
AGE AND SEX INCIDENCE IN BONE LESIONS (TABLE 1)
Age in 
years
Benign Malignant 
Male Female Male Female
Total
< 10 - - 2 - 2
11-20 12 5 10 6 33
21-30 7 6 9 5 28
31-40 5 4 5 3 17
41-50 1 2 3 2 8
51-60 2 - 7 4 13
61-70 - - 1 - 1
71-80 - - 2 1 3
Total 27 17 39 22 105
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A slight male predominance was noted (1.3 .1). Males constitute about 
66 cases (62.8%) and females constitute about 39 cases (37.2%).
Incidence of bone lesions (Benign and malignant)
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Out of 110 cases, there were 5 cases with inadequate material, excluded from 
the  study.  Of  105  cases,  malignant  constitutes  about  58.1%  and  benign 
constitutes about 41.9%.
INCIDENCE OF BONE LESIONS IN MALES 
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Both benign and malignant bone lesions are more common in males 
than in females.
DISTRIBUTION OF TUMOURS ACCORDING TO ANATOMIC SITE 
(TABLE 2)
SITE NO. OF CASES
Femur 50
Tibia 16
Humerus 8
Radius 8
Ileum 5
Ischium 1
Vertebra 5
Metatarsal 4
Metacarpal 2
Pelvis 2
Sternum 1
Nasal Bone 1
Scapula 1
Rib 1
Skull 2
Fibula 1
Maxilla 1
Of  110  cases,  the  two  most  common  site  of  presentation  of  bone 
tumours  were  the  femur  (50  cases)  and  the  proximal  tibia  (16)  cases, 
representing  the  two thirds  of  the  cases.  Other  sites  included the  humerus, 
radius, pelvis, ileum and vertebra. Of 67 FNA cases, there was no histological 
confirmation for 20 cases and the diagnosis was based on cytological analysis 
in combination with radiological and clinical features.
NATURE OF THE ASPIRATE 
(TABLE 3)
Nature of Aspirate No of Cases %
Adequate material 61 91%
Scant material 2 3%
Acellular 
(unsatisfactory)
4 6%
Adequate material for evaluation was obtained in 91% cases. Inadequate 
material for diagnosis was attributed to hemarrhagic material, necrotic material 
and paucity of material (2 cases in periosteal osteosarcoma).
GCT were seen to yield a large amount of material. Aspiration cytology 
is very effective in this tumour type. However clinico-radiological data must be 
considered to differentiate from other giant cell variants. Similarly round cell 
tumours  also  yielded  abundant  material  making  FNA  the  ideal  diagnostic 
procedure in this tumor type.
The technique of FNA seems to be ideally suited for the diagnosis of 
lytic bone lesions. One limitation of the technique is the difficulty in sampling 
a lesion that is covered by compact bone.
Diagnostic accuracy of FNAC of benign bone lesions  
(TABLE 4)
Benign lesions  Correct Incorrect Inconclusive
GCT 15 - 1
Other benign
Cartilaginous tumours 2 1 3
Osteochondroma 1 - -
Non ossifying fibroma 1 - -
DIAGNOSTIC ACCURACY OF FNA OF
MALIGNANT BONE LESIONS
(TABLE 5)
Malignant Lesions
Correct 
No. of 
cases
Incorrect
No. of 
cases
Inconclusive
No. of cases
Osteosarcoma 5 3 1
Chandrosarcoma 2 - -
Ewings Sarcoma 2 1 -
MFH 1 - -
Large cell lymphoma 1 - -
Secondary deposits 3 - 1
DIAGNOSTIC ACCURACY OF FNAC OF BONE LESIONS 
(TABLE 6)
Diagnosis Total no. of cases Percentage
Accurate 32 76.2%
Inconclusive 5 12.4%
Falsely benign 2 4.8%
Falsely malignant 2 4.8%
Materials considered conclusive for cytological diagnosis was obtained 
in 67 of the 110 cases.
A total of 25 lesions were cytologically assessed as benign. This was 
correct in 19 (76%) cases. One GCT was diagnosed as osteosarcoma.
30 cases were diagnosed as malignant and this was correct in 24 cases 
(80%). 
Of  the  30  malignant  cases,  the  cellular  yield  was  insufficient  (or) 
inconclusive in 2 cases.  It  required open biopsy to give the final diagnosis. 
These two cases were diagnosed as periosteal osteosarcoma by open biopsy 
and one as osteosarcoma telengiectatic variant.
Of  4  metastatic  deposits,  the  diagnosis  was  correct  in  3  cases  and 
inconclusive in one case, which was diagnosed as metastatic deposits by CNB 
and open biopsy.
The  overall  rate  of  correct  cytological  diagnosis  was  76.2%.  Falsely 
benign  diagnosis  was  4.8%.  one  osteosarcoma  was  diagnosed  as  GCT. 
Falsely malignant diagnosis was 4.8% one Aneurysmal bony cyst (ABT) with 
focal GCT transformation was diagnosed as synovial sarcoma.
One Ewings sarcoma was diagnosed as fibroblastic osteosarcoma.
Role of core needle biopsy in the diagnosis of bone tumours
A definitive diagnosis is made on the basis of the tumour histology and 
the clinical and radiographic confirmation.
Out of 110 cases, we received 30 core needle biopsies. Of 30 cases of 
CNB, resected specimens for 17 cases were received. For 13 cases, no resected 
specimens  were  available.  Two  biopsy  procedures  were  performed  under 
radiologic guidance, one under CT and another under USG.
DIAGNOSTIC ACCURACY OF CORE NEEDLE BIOPSIES 
OF BONE LESIONS
(TABLE 7)
Diagnosis Total no. of cases Percentage
Accurate 13 76.5%
Inconclusive 4 23.5%
Falsely benign 2 11.76%
Falsely malignant - -
Out of 17 CNB with confirmation 13 cases were diagnosed accurately 
(76.5%) and the material was inadequate in 4 cases (23.5%) and 2 cases were 
falsely  diagnosed  as  benign.  One  osteosarcoma  was  diagnosed  as 
chondromyxoid fibroma and one chondrosarcoma as benign chondroma.
One GCT was given as chondromyxoid fibroma and one osteitis fibrosa 
cystica was given as Aneurysmal bone cyst.
ADEQUACY OF MATERIAL IN CNB
TABLE 8
Total no. of cases Percentage
Adequate material 29 96.7%
Inadequate 1 3%
  
Out of 30 cases, a single core needle biopsy procedure was adequate in 
29 cases (96.7%) and inadequate in only one case (3%).
Comparison of results of this study with previously published data15.
(TABLE 9)
Study Years No. of 
biopsies
Adequate 
tissue%
Accuracy %
Washington 
Cancer 
Institute 
(WCI)
1992 – 1997 185 90.1% 72.7 – 92%
Prior data 1979 – 1997 472 83-100 64-100
Present Study 2004- 2006 30 96.7% 76.5%
Barth et al in a direct comparison of FNAC and core needle biopsy 
reported the core needle biopsy to be more accurate15. 
The distinct advantage of a core needle biopsy is that it provides a chunk 
of tissue that allows the pathologist  to examine the tumour architecture and 
interrelation of its cells. This is not possible with FNAC. 
In addition, a specimen taken from CNB can be subject to all of the 
special tests (or) stain to help determine the diagnosis.
Out  of  110  cases,  resected  specimens  were  available  for  3  open  biopsies. 
Histopathological diagnosis of open biopsies were compared with histological 
diagnosis after resection of the tumours. The diagnosis was correct in 3 cases.
One case was given as GCT in both open biopsy and resected specimen. 
Other case was given as pleomorphic spindle cell  sarcoma in the nature of 
malignant fibrous  histiocytoma in both open biopsy and resected specimen. 
One case was diagnosed as chondroma in resected specimen and as recurrent 
chondrosarcoma in open biopsy later.
DISCUSSION 
Our study suggest that FNAC is a valid option in the diagnosis of bone 
tumours.  It  s  a  simple  outpatient  procedure  which  offers  sufficient  tissue 
materials  for  the  correct  diagnosis  in  76.2% of  tumours.  As with the  open 
biopsy, however the cytological assessment must agree with the clinical and 
radiological  findings.  Our  results  are  encouraging,  but  FNAC  cannot 
completely replace open biopsy.
Dollahite et al in 1989 who reported a diagnostic accuracy of 83% of 
GCT, but a  significantly  lower rate for bone lesions thought to be benign8. 
.In our study diagnostic accuracy for GCT is 90%.
In out study, the main reason for failure was inadequate sampling rather 
than diagnostic difficulties.
In a comparitive study of 67 bone tumours Agarwal and Wahal (1983) 
showed diagnostic agreement between cytology and histopathology in 83%.
All failures were due to insufficient cytological material. Efforts should 
be made to improve the technique of obtaining adequate material.
The needle can be guided in different directions. Cortical bone has been 
penetrated and the device can easily be inserted at different sites in cortical 
bone without causing any major discomfort to the patient. This is important, 
since it is well known that a bone tumour can vary considerably histologically 
and tissue must be obtained from different areas of the same lesion.
For most bone tumours, however the distinction between benign bone 
tumours,  malignant  bone  tumours,  lymphomas,  myelomas  and  metastatic 
lesions is sufficient for correct management.
As  regards  treatment,  it  is  very  important  to  establish  the  correct 
histogenic tumour type and grade for conditions which required preoperative 
chemotherapy such as osteosarcoma and Ewings sarcoma.
As regards primary malignant bone tumours, our result imply that the 
greatest diagnostic difficulties are found with chondrosarcoma and periosteal 
osteosarcoma.
In  cytological  study  of  14  cases  of  Ewings  sarcoma,  Akerman  and 
Angervell (1986) concluded that the smear have characteristic appearance and 
that  FNAC  can  be  used  for  primary  diagnosis  and  also  for  chromosomal 
analysis  to  reveal  the  typical  11  :  22  translocation  of  Ewings  sarcoma. 
Osteosarcoma  seems  to  be  more  cytodiagnostic  difficulties  than  Ewings 
sarcoma but less so than chondrosaroma8.  
In our study of 9 cases of cytologically diagnosed osteosarcoma, 5 cases 
are  correct  (55%),  3  cases  are  incorrect  and  inadequate  in  one  case  of 
telengiectactic variant of osteosarcoma. One case was reported as GCT with 
secondary  ABC  changes,  another  as  chondrosarcoma  and  other  as 
adenocarcinoma  deposits.  In  4  cases  of  cytologically  diagnosed 
chondrosarcoma 2 cases are correct (50%).
Walas and Kindflom (1990) studied 20 high grade osteosarcomas, all 
the  cytological  specimens  showed  features  suggestive  of  primary  bone 
malignancy.  The  distinction  however  between  chondroblastic  osteosarcoma 
and high grade osteosarcoma and malignant fibrous histiocytoma proved to be 
difficult on smears.
There were 23 malignant bone tumours excluding secondary metastatic 
deposits with a biopsy accuracy of 91% and 25 benign tumours with a biopsy 
accuracy of 80% and metastatic tumours with a biopsy accuracy of 75%.
In the future, efforts should be focused on an improved biopsy technique 
to obtain a higher rate of conclusive cytological material. This can be done by 
an improved instrument design to facilitate multiple aspirates through cortical 
bone and also by wider application of CT.
Improved  diagnostic  accuracy  can  be  attained  by  the  use  of 
complementary  methods  such  as  electron  microscopy  and 
immunohistochemistry.
Objective  methods  such  as  DNA  cytometry,  proliferative  rate 
assessments, karyotyping and molecular genetics may also be of value.
These  methods  combined  with  clinical  experience  should  reduce  the 
need for open biopsy of bone tumours.
DIAGNOSTIC ACCURACY OF FNAC – COMPARATIVE ANALYSIS
(TABLE 10)
S.No. Authors Name Diagnostic 
Accuracy 
1. Texas M.D. Anderson Hospital6 (1978-1986) 80.4%
2. Arti Bhatia 19899 89%
3. Andris Breicbergs8 95%
4. Present study 76.2%
Out  of  47  cases,  32  cases  are  correctly  diagnosed  with  adequate 
material.  The  most  common  benign  tumours  are  GCT.  The  most  common 
malignant tumours are osteosarcoma.
ACCURACY OF ASPIRATE – COMPARITIVE ANALYSIS
(TABLE 11)
S.No. Authours 
Name
Satisfactory 
Aspirate
Unstatisfactory 
Aspirate
Falsely 
Benign
Falsely 
Malignant
1. Andri 
Kreicbergs 8 80% 16% 3% 0.3%
2. Texas MD 
Anderson 
Hospital6
(1978-1986)
85.7% 14.2% - -
3. Arti Bhatia9 
(1989) 92% 8% - -
4. Present Study 87.2% 12.4% 4.8% 4.8%
Out  of  47  cases,  a  satisfactory  sample  for  evaluation  of  cytological 
findings was obtained in 42 cases (87.2%) and in 5 cases (12.4%) the material 
was considered un satisfactory for reporting.
The  accuracy  rate  of  open biopsy  is  almost  100%.  The  one  case  of 
chondroma  and  subsequent  report  chondrosarcoma  can  be  explained  by 
differentiation of cartilaginous bone tumours, which is very common.
Fig : 1 :- GCT showing eccentrically located expansile lesion – Distal end of radius
Fig: 2:- GCT showing expansile and hemarrhagic lesion – Distal end of radius
Fig: 3:- Chondrosarcoma infiltrating in to the surrounding soft tissue - Distal radius
Fig: 4:- Chondrosarcoma - lobular cartilaginous mass showing gelatinous and 
hemorrhagic areas - Distal radius
Fig: 5:- Conventional osteosarcoma – Tumour is located at metaphysis with extension in 
to diaphysis involving the surrounding soft tissue.
Fig: 6:- Periosteal osteosarcoma showing lesion at the external surface of the 
bone – Lower end of femur.
Fig: 7:- GCT showing osteoclastic giant cells and mononuclear spindle cells in the 
stroma. HPE (x 100)
Fig: 8:- Giant cell tumour H& E (x 400)
Fig: 9:- Osteosarcoma showing pleomorphic spindle ad round cells-H & E (x 100)
Fig: 10:- Osteosarcoma showing osteoid in between cells in clusters 
H &E(x 400)
Fig: 11:- Chondroblastic osteosarcoma showing pleomorphic sarcoma cells in chondroid 
matrix H &E(x 100)
 
Fig: 12:- Chondrosarcoma showing irregular nuclei and binucleate forms in chondroid 
matrix H &E(x 100)
Fig: 13:- Chondrosarcoma H &E(x 400)
Fig: 14:- Ewings sarcoma - Rosette like arrangement H&E (x 100)
Fig: 15:- Ewings sarcoma – showing uniform small round cells with scanty cytoplasm 
and Rosette like structures H&E (x 400)
Fig: 16:- Secondary deposits from thyroid showing follicular arrangement of thyroid 
epithelial cells – follicular carcinoma H&E (x 100)
Fig: 17:- Secondary deposits from follicular carcinoma thyroid showing colloid 
H&E (x 400)
Fig: 18:- Secondary deposits from squamous cell carcinoma H&E (x 100)
Fig: 19 :- SCC deposit showing pleomorphic cells with dense cytoplasm and well defined 
cell borders H&E (x 400)
Fig: 20 :- Giant cell tumour showing uniform distribution of osteoclastic giant cells in a 
background of stromal cells &E (x 100)
Fig: 21 :- Chondromyxoid fibroma showing lobulated chondroid neoplasm with myxoid 
and fibroid areas H&E (x 100)
Fig: 22 :- Chondromyxoid fibroma showing stellate cells in myxoid areas H&E (x 400)
Fig: 23 :- Fibrous dysplasia showing fish hook configuration H&E (x 100)
Fig: 24 :- Conventional osteosarcoma showing osteoid produced by the tumour cells 
H&E (x 100)
Fig: 25 :- Conventional osteosarcoma showing osteoid [Network of fine lace like 
trabeculae of bone] H&E (x 400)
Fig: 26 :- Chondroblastic osteosarcoma showing chondroid areas with malignant spindle 
cells and osteoid H&E (x 100)
Fig: 27 :- Chondroblastic osteosarcoma showing osteoid H&E (x 400)
Fig: 28 :- Chordoma showing lobules of tumour cells H&E (x 100)
Fig: 29 :- Chordoma - physalliferous cells showing vacuolated cytoplasm H&E (x 400)
Fig: 30:- High grade osteosarcoma  H&E (x 100)
Fig: 31:- High grade osteosarcoma  showing pleomorphic and hyperchromatic 
malignant osteoblast H&E (x 400)
Fig: 32:- Pleomorphic spindle cell sarcoma – Malignant fibrous histiocytoma of bone 
H&E (x 100)
Fig: 33:- Telengiectatic osteosarcoma showing malignant stroma in the septa and blood 
filled vascular spaces          H&E (x 100)
Fig: 34:- Ewings sarcoma showing uniform small round cells with very scanty cytoplasm 
and Rosette like structures H&E (x 100)
Fig: 35:- Ewings sarcoma - Rosette like arrangement of uniform small round cells 
H&E (x 400)
Fig: 36:- Secondary deposits from follicular carcinoma thyroid H&E (x 100)
Fig: 37:- Secondary deposits from follicular carcinoma thyroid H&E (x 400)
Fig: 38:- Secondary deposits from squamous cell carcinoma cervix H&E (x 400)
CONCLUSION 
We evaluate the diagnostic accuracy of FNAC and CNB in a study of 
110 cases. Patients with suspected local recurrence of a primary bone tumour 
and metastasic lesion of a previously diagnosed malignancy were included.
Maximum  no  of  cases  (36.4%)  were  observed  in  the  age  group  of 
11-20 yrs. Of 110 cases in the study, males constituted for 62.8% and females 
37.2%. In the present study benign lesions were observed in 44 cases (41.9%) 
and malignant lesions in 61 cases. In our study, the most common site of lesion 
are femur (50 cases) and tibia (16 cases). Among the benign lesions, GCT is 
the commonest one and osteosarcoma is the commonest maliagnant lesion.
We  compared  the  cytological  diagnosis  with  the  final  diagnosis  as 
assessed by histological examination and clinical, radiological features.
Material considered conclusive for cytological diagnosis was obtained 
from 67  cases  of  110  patients.  The  biopsy  specimen  for  comparison  were 
available for 47 cases only. The diagnosis was correct in 32 cases (76.2%) of 
the  42  cases  providing  adequate  cytological  material.  There  were  2  (4.8%) 
falsely malignant diagnosis.
We compared the core needle biopsy diagnosis as for cytology. CNB 
was obtained from 30 cases. Resected specimens were obtained for 17 cases. 
Out of 30 cases,  a single core needle biopsy procedure was adequate in 29 
cases 96.7% and inadequate in only one case (3%) and the diagnostic accuracy 
is 76.5%.
Comparative analysis  of  diagnostic  accuracy of  FNAC and CNB in present 
study     
Procedure Adequate 
tissue %
Diagnostic Accuracy
FNAB 91% 76.2%
CNB 96.7% 76.5%
Our study suggest that FNAC is the most useful technique in diagnosis 
of bone tumors 
1. It is a simple outpatient procedure 
2. It gives sufficient cytological materials for the correct diagnosis of cases.
3. FNAC can be effectively used in the screening of various bone lesions and 
their management. 
4. Low cost  and lack of complications have made FNA cytology the most 
preferred and initial test in the evaluation of a mass lesion, compared to 
CNB. 
5. Tumor dissemination is minimal
6. Ancillary methods can be applied
In our study, the main reasons for failure was inadequate sampling rather 
than diagnostic difficulties. Which can be corrected by repeating the aspirate.
Though open biopsy has 100% accuracy in the diagnosis of malignant bone 
tumurs,  FNAC is the best  method of pre operative evaluation to arrive at a 
definitive  diagnosis,  because  open  biopsy  involves  hospitalization, 
traumatizing procedures and tumour dissemination.  
PROFORMA
Department of Pathology
MMC, Chennai
Name :
Age : I.P. No. :
Sex : FNAC. No. :
Occupation : CNB No. :
Address : Open biopsy No. :
History : Past History :- 
H/o Trauma
H/o drug intake
H/o Radiation
Present history :- 
Complaints
Duration 
Family History :- Similar C/o
O/E : Bone :- 
Site of lesion – Single/ Multiple
Size and Shape 
Tenderness 
Consistency
Investigations :-
1. Radiological – X-ray :- Lytic/ Sclerotic/ Mixed
Extension with in bone
Soft tissue extension
Peripheral Sclerosis 
    Spotty 
Calcification 
    Fluffy
    Chicken Wire
MRI/ CT
2. Serological – Sr. alkaline phosphatase 
3. FNAC
4. Core needle biopsy
5. Open biopsy 
Histopathological Examination :-
Gross :
Microscopy :
Diagnosis :
Remarks 
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MASTER CHART
Sr. 
No. Age Sex Site X-ray/ CT/ MRI FNAC CNB Open biopsy
1. 15 F Lt. Hand (4th) meta carpal osteolytic 3620/04 → Giant cell tumour - 4420/ 04 → Giant cell tumour
2. 46 F Upper 1/3 Femur Osteolytic lesion with 
osteosclertic rim 
- 4107/04 : Fibrous 
dysplasia
4574/ 04 : Fibrous dysplasia
3. 26 M Upper 1/3 Femur Epiphysis – osteolytic 5694/04 :- GCT - 6770/ 04 :- GCT
4. 28 F Lower 1/3 Femur Epiphysis – osteolytic 5873/04 :- GCT - 6814/ 04 :- GCT
5. 24 M Lt Knee Sclerotic lesion lateral tibial 
condyle
6425/04 :- GCT 
Chondroblastoma -
6425/ 04 :- GCT Chondroblastoma
6. 19 F Lt distal radius Osteolytic lesion-distal end 
of radios
5290/04 :- GCT 
Chondroblastoma sarcoma
4569/04 :- well 
Differentiated chrondro 
sarcoma 
6000/ 04 :- Chondroblastoma 
7. 17 F Upper 1/3 tibia 
(Rt)
Osteolytic :- (Rt) medial 
condyle of Tibia
2922/04 :- osteo sarcoma 4133/04 :- Aggressive 
GCT
3269/ 04 :- GCT rich osteo 
sarcoma/ High grade GCT 
8. 22 F (Rt) distal redius Osteolytic lesion epiphysis - 3048/04 :- GCT 3454/ 04 :- GCT
9. 39 F (Lt) Upper 
humerus
Osteolytic 4475/04 :- GCT - 5505/ 04 :- osteo sarcoma
10. 12 M (Lt) Upper 1/3 
thigh
Expansile lesion – Upper 1/3 
of femur 
5749/ :- Inadequate material -  7/ 04 :- Peri osteal osteo sarcoma 
11. 38 M (Lt) maxilla Proliferating mass-(Lt) Nasal 
cavity
2238/04 :- large cell 
lymphoma 
2404/04 :- Large cell 
lymphoma/ 
undifferentiated carcinoma
2374/ 04 :- lymphoma/ 
undifferentiated carcinoma
12. 18 M (Lt) thigh Osteolytic lesion (H) femur – 
lower lateral aspect 
periosteal elevation (F)
981/04 :- Inadequate 
material 1160/04 :- osteo sarcoma
-
13. 20 M (Lt) Upper tibia - 1026/04 :- S/o cartilaginous 
neoplasm -
1329/ 04 :- Chondroblastic OS
Sr. 
No. Age Sex Site X-ray/ CT/ MRI FNAC CNB Open biopsy
14. 18 F (Rt) Lower femur Osteolytic lesion – 
metaphysic and epiphysis
- 6849/04 :- GCT 7103/ 04 :- GCT
15. 17 M (Rt) Upper thigh Osteolytic lesion – Epiphysis 
femur
415/04 :- GCT 499/04 :- GCT 6881/ 04 :- GCT
16. 65 M (Rt) ileum Cotton wool appearance - - 5886/ 04 :- osteo sarcoma
17. 56 M Lumbar region
L1
? Carries spice 
? Secondaries 
- 2993/04 :- Follicular Ca 
deposit
-
18. 11 M (Rt) Upper Leg Osteoslerotic - - 1599/ 04 :- Chondroblastoma osteo sarcoma
19. 70 M (Rt) lower 1/3 
femur  
- - - 991/04 :- osteochondoma 
20. 38 M (Lt) Needle of 
femur
Osteolytic - - 1286/ 04 :- osteoblastic osteo sarcoma
21. 65 M (Rt) Knee - 325/05 :- GCT - 3041/ 05 :- GCT 
22. 53 F (Lt) foot - 2520/ 05 :- Synovial 
sarcoma -
2220/ 05 :- ABC with focal GCT 
transformation 
23. 25 M (Lt) humerius Mixed osteolytic and 
osteoblastic  
3477/ 05 :- Small round cell 
tumor P/o. Ewings
2843/ 05 :- Small round 
cell
-
24. 60 F Pelvis Expansile osteolytic 1403/ 06 :- Chrondoma 1173/ 06 :- Inadequate -
25. 35 F (Rt) elbow Osteolytic 6502/ 04 :- GCT - 71/ 05 :- GCT
26. 72 F (Lt) tibia Osteolytic 5922/ 05 :- Plenty of plasma 
cells with few lymphocytes -
4951/ 05 :- MFH
27. 57 M Sterium - 957/ 05 :- Secondary adeno 
ca deposits -
1518/ 05 :- secondary metastatic 
deposits – poorly differentiated ca
28. 25 M (Lt) femur Osteolytic Benign cartilaginous tumour 5979/ 05 :- Chondrama 1197/ 06 :- Chondro Sarcoma 
29. 46 F Upper 1/3 femur Osteolytic 1358/ 06 :- Osteo Sarcoma - 2106/ 06 :- GCT with secondary ABC changes
30. 24 M (Rt) Radius Osteolytoc lesion 6612/ 06 :- GCT 1076/ 06 :- GCT 1420/ 06 :- GCT
31. 55 F (Rt) Upper thigh Secondary deposits 6368/ 05 :- Metastatic 
deposit from thyroid  -
5321/ 05 :- Metastatic deposits 
from thyroid 
Sr. 
No. Age Sex Site X-ray/ CT/ MRI FNAC CNB Open biopsy
32. 17 M (Rt) humerous Osteolytic and new bone 
formation 
- 1383/ 06 :- Osteo Sarcoma 1762/ 06 :- osteo sarcoma
33. 39 M (Lt) ischium Osteolytic 6923/ 05 :- GCT rich MFH 5833/ 05 :- MFH – Giant 
cell variant 
-
34. 76 M (Rt) humerous Osteolytic - 5967/ 05 :- positive for 
malignancy
-
35. 45 M (Lt) femur Osteolytic and speck eld 
calcification 
5433/ 05 :- chondro sarcoma - 5263/ 05 :- Malignant chondrogenic tumours
36. 27 M (Lt) tibia Osteolytic 575/ 05 :- GCT - 1136/ 05 :- GCT
37. 18 M (Lt) distal femur Cortical destruction and 
periosteal reaction 
- - 183/ 05 :- Osteo Sarcoma
38. 21 M (Rt) tibia Osteolytic 7810/ 05 :- Osteo Sarcoma - 125/ 06 :- Osteo Sarcoma Telengiectatic variant
39. 20 F (Rt) ileum Osteolytic 8142/ 05 :- Sarcoma of 
osteoblastic origin 
6742/ 05 :- 
Dedifferentiated chondro 
sarcoma  
338/ 06 dedifferentiated chondro 
sarcoma  
40. 20 M (Lt) distal femur Osteolytic lesion and cortical 
destruction 
6826/ 05 :- Osteo Sarcoma 1160/ 04 :- osteosarcoma 
– osteoclastic type
-
41. 60 F (Lt) thigh Pathological fracture Neck of 
femur
6481/ 05 :- Inadequate 1951/ 06 :- Secondary sec 
deposits
2230/ 06 :- Secondary scc deposits 
– large cell keratinizing type
42. 25 F (Lt) Nasal bone - - - 6130/ 05 :- Ossifying fibroma
43. 25 M (Lt) Upper thigh Osteolytic - - Chondra Sarcoma
44. 14 M (Lt) Upper femur Osteolytic - - 6210/ 05 :- Ossifying fibroma
45. 35 F (Lt) metatarsal Expansile osteolytic - - 6519/ 05 :- GCT
46. 17 M (Rt) lower thigth Osteolytic lesion with cortical 
destruction
- - 6795/ 05 :- chondroblastic osteo sarcoma
47. 60 M Lumber 
vertebrae - L1
Lytic lesion - - -
48. 29 F (Rt) lower thigh Thinned out cortex - - 6985/ 05 :- GCT
49. 18 M (Rt) iliac bone Osteolytic lesion 7995/ 05 :- small round cell 
tumour -
-
Sr. 
No. Age Sex Site X-ray/ CT/ MRI FNAC CNB Open biopsy
50. 26 M (R) upper tibia Fracture medial condyle 649/ 06 :- Hemarrhagic 
Smear -
775/  06  :-  Schwanomma  /  Low 
grade MPNST
51. 78 F (Rt) Upper femur - 504/ 06 :- inadequate 
material -
893/ 06 :- Telengiectatic variant of 
steosarcoma
52. 29 F (Lt) Scapula Osteolytic 854/ 06 :- CMF 1071/ 06 :- Chondro 
myxoid fibroma
-
53. 21 M Lower 1/3 (Rt) 
thigh
Solitary osteo chondroma 1566/ 06 :- osteochondroma 1634/ 06 :- 
osteochondroma
2186/ 06 :- osteochondroma
54. 50 F (Rt) Radius Mixed type of lesion 1765/ 06 :- chondro sarcoma - 2331/ 06 :- Low grade chondro sarcoma
55. 50 F (Rt) femur Subtrochanteric fracture 6862/ 05 :- chondro sarcoma 1747/ 06 :- Occasional 
clusters of hyperchromatic 
epithelial cells
1990/ 06 :- Adeno carcinomatous 
deposits
56. 55 F (Lt) lower 
hmerous 
Osteolytic lesion 3683/ 06 :- Chrondro 
sarcoma – grade II -
3654/ 2000 :- chondro sarcoma
57. 24 M Rt upper tibia Osteolytic lesion and 
pathological fracture 
2480/ 06 :- Smear is positive 
for malignancy 2731/ 06 :- osteo sarcoma
-
58. 12 M (Rt) Scapula Osteolytic lesion 168/ 05 :- Small round cell 
tumour
222/ 06 :- Round cell 
tumour P/o. Ewings 
-
59. 14 F (Lt) distal femur Exostosis 3110/ 06 :- Benign lesion - 3929/ 06 :- osteochondroma
60. 30 F Lumber 
vertebrae 
L1, L2, L3,
Destructive changes 3681/ 06 :- Keratinizing SCC 
deposits 
Secondary Ca deposits 
from poorly differentiated 
carcinoma 
-
61. 42 F (Rt) tibia Osteolytic lesion with cortical 
destruction 
2802/ 06 :- GCT rich 
osteosarcoma 
Pleomorphic spindle cell 
sarcoma in the nature of 
MFH
4237/ 06 :- Pleomorphic spindle 
cell sarcoma in the nature of MFH
62. 31 F (Rt) foot - 3595/ 06 :- Extra skeletal 
Ewings sarcoma -
3274/ 06 :- Round cell tumour 
P/o : Ewings 
Sr. 
No. Age Sex Site X-ray/ CT/ MRI FNAC CNB Open biopsy
63. 20 F (Rt) distal radius Osteolytic lesion 2786/ 06 :- GCT - 3507/ 06 :- GCT
64. 35 F (Rt) distal femur Osteolytic lesion 3815/ 06 :- Non ossifying 
fibroma -
3785/ 06 :- Benign fibrous lesion
65. 18 F (Rt) Second 
metatarsal bone
- ? Fibroma - 4067/ 06 :- Neurofibroma 
66. 12 F (Lt) Proximal 
tibia
- 4269/ 06 :- Ewings sarcoma - 4100/ 06 :- Fibroblastic osteosarcoma
67. 45 F (Lt) Proximal 
femur
- - 1170/ 06 :- Anurysmal 
bony cyst.
1950/ 06 :- Osteitis fibrsa cytica
68. 23 F (Lt) distal femur Osteolytic lesion 3854/ 06 :- Osteo 
chondroma -
-
69. 15 F (Lt) knee Mixed sclerotic and lytic 
lesion-Tibia
3869/ 06 :- Osteo Sarcoma - 4440/ 06 :- High grade osteosarcoma.
70. 22 M (Rt) leg Osteolytic lesion – Middle 
1/3 of Tibia
? Osteosarcoma
? Ewings sarcoma 
3981/ 06 :- Ewings Sarcoma
-
-
71. 58 M (Rt) leg Osteolytic lesion upper 1/3 
tibia
4133/ 06 :- smear is positive 
for malignancy -
-
72. 38 M (Rt) ring finger Osteolytic 4381/ 06 :- GCT - -
73. 46 F Osteolytic lesion 3, 4, 5 ribs 4454/ 06 :- Lympho 
proliferative disorder -
-
74. 44 M Rt thigh Osteolytic lesion with 
irregular cortex
5028/ 06:- chondro sarcoma - -
75. 27 F (Lt) 5th meta 
carpal
- 3574/ 06 :- chondroma - -
Sr. 
No. Age Sex Site X-ray/ CT/ MRI FNAC CNB Open biopsy
76. 59 M Para  vertebral 
region
(1) Chondro Sarcoma
(2) Extra osseous 
Soft tissue osteasarcoma
3500/ 06 :- Papillary adeno 
carcinomatous deposit 
- -
77. 50 F Ileum    Osteolytic - 200/ 06 :- chondrosarcoma 1002/ 06 :- chondrosarcoma – Gr II
78. 15 M (Lt) distal femur Diaphysis : osteolytic lesion 
with soft tissue component
749/ 06 :- organizing 
hematoma
3657/ 06 :- Peri osteal 
osteosarcoma
-
79. 75 M (Rt) Maxilla - - - Squamous cell carcinoma
80. 22 F (Rt) Mid 1/3 
femur
Destructive lesion with 
fracture shaft of femur
- 3039/ 06:- spindle cell 
sarcoma (1) synovial 
sarcoma
(2)  MPNST
2288/ 06 :- spindle cell sarcoma 
(1) synovial sarcoma
(2) MFH
81. 10 M (Rt) proximal 
Tibia
Diffuse periosteal 
osteosclerotic lesion
- - 2414/ 06 :- High grade osteo sarcoma
82. 53 F (Lt)distal femur Eccentric osteolytic lesion - - 2561/ 06 :- GCT
83. 36 M (Rt) distal radius Expansile lytic lesion - - 2607/ 06 :- High grade GCT
84. 18 F (Rt) distal femur Expansile lytic lesion - - 2984/ 06 : GCT
85. 16 M (Lt) femur Exostosis - - 3011/ 06 :- osteochondroma
86. 30 M (Lt) femur Exostosis - - 3037/ 06 :- osteochondroma
87. 32 F (Rt) lower end of 
radius
Osteolytic lesion 4270/ 06 :- GCT - -
88. 26 M (Rt) distal femur Osteolytic lesion – 
metaphysic 
- - 3282/ 06 :- osteasarcoma – osteoclastic type 
89. 11 M (Rt) distal femur ? Ewings sarcoma - - 3492/ 06 :- exostosis 
90. 40 F L4 – L5 ? Carries spine - - 3530/ 06 :- chondroma
91. 20 M (Rt) distal 
humerous 
Osteoblastic lesion with Peri 
osteal elevation
- - 3574/ 06 :- Chondroblastic osteosarcoma
92. 15 M (Lt) femur - - - 3657/ 06 :- High grade osteosarcoma- Chondroblastic type
93. 14 M (Lt) femur Exostosis - - 3669/ 06 :- Osteochondroma
Sr. 
No. Age Sex Site X-ray/ CT/ MRI FNAC CNB Open biopsy
94. 35 M (Lt) femur Exostosis - - 3709/ 06 :- Osteochondroma
95. 14 M (Rt) humerous Exostosis - - 3723/ 06 :- Osteochondroma
96. 49 M Pelvis Osteolytic lesion - - 3885/ 06 :- chondroma
97. 47 F Rt ileum ? ABC
? GCT
- - 4018/ 06 :- Neurogenic tumour/ muloid liporatous tumour
98. 20 M Rt femur Supra condylar fracture - - 2432/ 06 :- Chondroblastic
99. 35 M Lt femur Osteoblastic lesion - 3223/ 06 :- Chondro 
myxoid fibroma 
4259/ 06 :- Osteosarcoma
10
0.
20 M ? Clival 
chondroma
? control destructive lesion 
in central skull base
- - 2618/ 06 :- GCT
10
1.
20 M Parietal bone Lytic lesion - - 2623/ 06 :- Fibrous dysplasia
10
2.
18 M (Lt) lower femur Osteolytic lesion 5235/ 06 :- inadequate 
material -
-
10
3.
40 M (L) upper 
humerous 
Osteolytic lesion 5259/ 06 :- plasmacytomea - -
10
4.
17 M (Lt) proximal 
fibular
Osteolytic lesion 5283/ 06 :- Small cell 
osteosarcoma -
-
10
5.
37 M (Lt) femur Lytic lesion- Metaphyseo 
epiphyseal 
4743/ 06 :- Inadequate 
material -
4442/ 06 :- Desmoplastic fibroma
10
6.
11 F Rt distal femur Diffuse osteolytic/ 
osteoblastic lesion
- - 4306/ 05 :- osteosarcoma
10
7.
33 F (Lt) proximal 
femur
Osteolytic lesion with cortical 
destruction 
- - 4858/ 05 :- wall differentiated chondro sarcoma 
10
8.
19 M (Rt) ank;e 
calcanium 
Sclerotic lesion 4275/ 06 :- Malignant 
chondroid neoplasm -
5160/ 06 :- Chondroblastic variant 
of Osteosarcoma
10
9.
05 M (Lt) distal femur Lytic lesion with periosteal 
elevation
5655/ 06 :- Ewings sarcoma - 5233/ 06 :- chronic non specific osteomylitis
11
0.
54 F (Lt) leg Erosion (+) Tibial 
mataphysis
5224/ 06 :- chondrosarcoma - -

